ABVC vs NUE · rev $796.0K vs P/E 25, rev $19.89B
ABVC Biopharma Inc (ABVC) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
ABVC currently screens at market cap $35.9M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the ABVC and NUE stock pages for the full models.
Not investment advice.